JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

BA9325 Fmoc-B-HoPhe-OH

Summary: A phenylalanine derivative.
A4488 Anacardic acid
1 Citation

Target: Histone Acetyltransferases (HATs)

Summary: HAT inhibitor

insoluble in H2O; ≥17.45 mg/mL
A8234 Erlotinib Hydrochloride
2 Citation

Summary: Selective EGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
A8237 SKLB610

Summary: Potent VEGFR inhibitor

insoluble in H2O; ≥20.75 mg/mL
A8248 ZSTK474

Summary: Potent PI3K inhibitor

insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
A5770 Sulfasalazine

Summary: NF-κB activation inhibitor

insoluble in ETOH; insoluble in H2O; ≥17.7 mg/mL
A8412 Dinaciclib (SCH727965)
5 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK inhibitor
A8644 Acyclovir
2 Citation

Target: HSV

Summary: Antiviral agent

insoluble in H2O; insoluble in EtOH; ≥11.4 mg/mL
A8808 ME0328

Target: PARP

Summary: PARP inhibitor,potent and selective

≥71.43 mg/mL
B3232 Z-IETD-FMK
35 Citation

Target: Caspases

Summary: Caspase-8 inhibitor

≥32.73 mg/mL